WHO ICTRP trial
Effect of dexamethasone in patients with brain hemorrhage
CTRI/2023/04/051314 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2023/04/051314 |
|---|---|
| Public title | Effect of dexamethasone in patients with brain hemorrhage |
| Scientific title | Effect of dexamethasone in patients with primary intracerebral hemorrhage - a pilot prospective randomized open blinded endpoint study (PROBE design). |
| Primary sponsor | AIIMS, New Delhi |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: I610- Nontraumatic intracerebral hemorrhage in hemisphere, subcortical |
| Interventions | Intervention1: Dexamethasone: Drug: Dexamethasone Dose: 0.4 mg/kg per day in three divided doses (maximum dose of 40 mg/day) administered intravenously or per orally. Duration: 7 days Control Intervention1: STANDARD OF CARE: STANDARD OF… |
| Registration date | May 4, 2023 |
| Target size | 100 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: